Literature DB >> 25092780

Clinical trial evidence of the antitumor activity of topical imiquimod for breast cancer skin metastases.

Sylvia Adams1, Yelena Novik2, Ruth Oratz2, Deborah Axelrod2, James Speyer2, Amy Tiersten3, Judith D Goldberg2, Nina Bhardwaj3, Derya Unutmaz2, Sandra Demaria2, Silvia Formenti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25092780     DOI： 10.1200/JCO.2014.56.1282

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Exercise as Adjunct Therapy in Cancer.

Authors:  Kathleen A Ashcraft; Allison Betof Warner; Lee W Jones; Mark W Dewhirst
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 2.  Charting roadmaps towards novel and safe synergistic immunotherapy combinations.

Authors:  Miguel F Sanmamed; Pedro Berraondo; Maria E Rodriguez-Ruiz; Ignacio Melero
Journal:  Nat Cancer       Date:  2022-06-28

3.  Successful treatment of cutaneous metastatic breast cancer with topical treatments that potentially synergize with systemic therapy: A case series.

Authors:  Shalini R Krishnasamy; Timothy H Almazan; Giselle A Suero-Abreu; Jae Y Jung
Journal:  JAAD Case Rep       Date:  2018-08-15

4.  Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.

Authors:  Stefanie R Mullins; John P Vasilakos; Katharina Deschler; Iwen Grigsby; Pete Gillis; Julius John; Matthew J Elder; John Swales; Elina Timosenko; Zachary Cooper; Simon J Dovedi; Andrew J Leishman; Nadia Luheshi; James Elvecrog; Ashenafi Tilahun; Richard Goodwin; Ronald Herbst; Mark A Tomai; Robert W Wilkinson
Journal:  J Immunother Cancer       Date:  2019-09-11       Impact factor: 13.751

5.  Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors.

Authors:  Lillian Siu; Joshua Brody; Shilpa Gupta; Aurélien Marabelle; Antonio Jimeno; Pamela Munster; Juneko Grilley-Olson; Alain H Rook; Antoine Hollebecque; Rebecca K S Wong; James W Welsh; Yuling Wu; Christopher Morehouse; Oday Hamid; Farzana Walcott; Zachary A Cooper; Rakesh Kumar; Charles Ferté; David S Hong
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.